Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Aarhus Universitet Forside
Hjælp og OSS
English
Dansk
Forside
Profiler
Forskningsenheder
Projekter
Publikation
Priser
Aktiviteter
Kurser
Presse/medier
Søg efter ekspertise, navn eller tilknytning
Vis Scopus-profil
Peter Ott
Professor emeritus
,
Institut for Klinisk Medicin - Lever-, Mave- og Tarmsygdomme
E-mail
peter.ott
clin.au
dk
Palle Juul-Jensens Boulevard 35
8200
Aarhus N
Danmark
2000
2025
Publikationer pr. år
Vis
Fingeraftryk
Netværk
Publikation
(125)
Aktiviteter
(3)
Lignende profiler
(8)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Peter Ott er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Medicine and Dentistry
Liver Cirrhosis
100%
Wilson's Disease
52%
Hepatic Encephalopathy
43%
Cohort Analysis
39%
Liver Disease
38%
Positron Emission Tomography
31%
Ammonium
30%
Disease Course
30%
Alcohol Liver Cirrhosis
29%
Primary Biliary Cirrhosis
29%
Carbon 11
29%
Ursodeoxycholic Acid
24%
Blood Flow
22%
Radioactive Tracer
20%
Galactose
19%
Patient with Cystic Fibrosis
19%
Copper 64
19%
Disease
19%
Secretion (Process)
17%
Cholestasis
17%
Bile Acid
15%
Liver Transplantation
15%
Positron Emission Tomography-Computed Tomography
15%
Hepatocellular Carcinoma
14%
Cohort Effect
14%
Bile Acid Conjugate
14%
Ascites
14%
Brain Blood Flow
13%
Disease Severity
13%
Common Hepatic Artery
12%
Oxygen Consumption
12%
Macrophage Activation
12%
Hyperammonemia
12%
Clinical Trial
11%
Transport Kinetics
11%
Computed Tomography Studies
11%
Sarcosine
10%
Liver Fibrosis
9%
Detoxication
9%
Budesonide
9%
Kayser-Fleischer Ring
9%
Transjugular Intrahepatic Portosystemic Shunt
9%
Radiation Therapy
9%
Hyponatremia
9%
Selective Internal Radiation Therapy
9%
Postprandial State
9%
Microsphere
9%
Branched Chain Amino Acid
9%
Liver Metastasis
9%
Transcatheter Arterial Chemoembolization
9%
Pharmacology, Toxicology and Pharmaceutical Science
Normal Human
72%
Wilson's Disease
54%
Carbon 11
39%
Copper 64
39%
Liver Cirrhosis
38%
Bile Acid Conjugate
34%
Primary Biliary Cirrhosis
29%
Hyperammonemia
24%
Ursodeoxycholic Acid
24%
Tracer
23%
Ammonium
22%
Liver Disease
21%
Cohort Study
19%
Penicillamine
19%
Trientine
19%
Alcohol Liver Cirrhosis
19%
Bile Acid
17%
Disease
16%
Obeticholic Acid
14%
Alcohol Liver Disease
13%
Clinical Trial
12%
Computed Tomography Studies
12%
Biodistribution
12%
Sarcosine
10%
Placebo
10%
Elimination
9%
Tetrathiomolybdic Acid
9%
Budesonide
9%
Liver Cell Carcinoma
9%
Disease Severity
9%
Cholecalciferol
9%
Randomized Controlled Trial
9%
Glutamate Ammonia Ligase
9%
Galactose
9%
Vitamin D
9%
Ornithine Phenylacetate
9%
Prevalence
9%
Tezacaftor
9%
Cystic Fibrosis
9%
Ergocalciferol
9%
Ivacaftor
9%
Branched Chain Amino Acid
9%
Dosimetry
9%
Amino Acid
9%
Hepatic Encephalopathy
8%
Cholestasis
8%
Methionine Sulfoximine
7%
Glutamine
7%
Chronic Liver Disease
7%
End Stage Liver Disease
6%
Biochemistry, Genetics and Molecular Biology
Metabolic Pathway
51%
Amino Acids
50%
Normal Human
39%
Glutamine
30%
Ammonia Blood Level
26%
Homeostasis
24%
Alanine
21%
Cohort Study
19%
Glutamate Dehydrogenase
19%
Prevalence
19%
Galactose
19%
Citric Acid Cycle
16%
Isoleucine
15%
Glutamine Synthetase
14%
Cell Culture
14%
Positron Emission Tomography
14%
Enzyme
13%
Transport Kinetics
13%
Aerobic Metabolism
11%
Genotyping
11%
Mitochondrial Membrane Transport Protein
11%
Transport Protein
11%
Mouse
10%
Rat Model
9%
Exon
9%
Allele
9%
Membrane Potential
9%
Promyelocyte
9%
CD163
9%
Autosomal Recessive Disorder
9%
Pressure Gradient
9%
Venous Pressure
9%
Amino Acid Blood Level
9%
Neurotoxin
9%
Macrophage Activation
9%
Ammonia Formation
9%
Binding Domain
9%
Copper Metabolism
9%
P-Type ATPase
9%
Metal Binding
9%
ATPase
7%
Lactulose
7%
Genetic Screening
6%
Methionine
6%
Heterozygote
6%
Genetic Carrier
6%
Biliary Excretion
6%
Absorption
6%
Choline
6%
Positron Emission Tomography-Computed Tomography
6%
